Occult brain metastases in her-2-positive breast cancer patients

被引：0
|
作者：
不详
机构：
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [1] Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases
    Frenel, Jean-Sebastien
    Bally, Olivia
    Bourbouloux, Emmanuelle
    Berton-Rigaud, Dominique
    Campone, Mario
    Bachelot, Thomas
    Heudel, Pierre-Etienne
    BULLETIN DU CANCER, 2016, 103 (05) : 507 - 510
  • [2] Occult brain metastases in HER2-positive breast cancer patients: Frequency and response to radiotherapy
    Niwinska, Anna
    Tacikowska, Malgorzata
    Pienkowski, Tadeusz
    ACTA ONCOLOGICA, 2007, 46 (07) : 1027 - 1029
  • [3] Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts
    Bartolotti, Marco
    Franceschi, Enrico
    Brandes, Alba A.
    FUTURE ONCOLOGY, 2013, 9 (11) : 1653 - 1664
  • [4] Effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival
    Niwinska, A.
    Tacikowska, M.
    Lemanska, I.
    Pienkowski, T.
    Murawska, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] The incidence and treatment outcome after radiotherapy for brain metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab
    Arif, S.
    Barrett-Lee, P. J.
    Jordan, C.
    CLINICAL ONCOLOGY, 2006, 18 (09) : 719 - 720
  • [6] Brain metastases in HER2-positive breast cancer
    Lin, Nancy U.
    LANCET ONCOLOGY, 2013, 14 (03): : 185 - 186
  • [7] Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
    Mariantonietta Colozza
    Elisa Minenza
    Stefania Gori
    Daniela Fenocchio
    Cristina Paolucci
    Cynthia Aristei
    Piero Floridi
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1157 - 1159
  • [8] Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
    Colozza, Mariantonietta
    Minenza, Elisa
    Gori, Stefania
    Fenocchio, Daniela
    Paolucci, Cristina
    Aristei, Cynthia
    Floridi, Piero
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1157 - 1159
  • [9] THE EFFECT OF EARLY DETECTION OF OCCULT BRAIN METASTASES IN HER2-POSITIVE BREAST CANCER PATIENTS ON SURVIVAL AND CAUSE OF DEATH
    Niwinska, Anna
    Tacikowska, Malgorzata
    Murawska, Magdalena
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1134 - 1139
  • [10] Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients
    Bighin, Claudia
    Pronzato, Paolo
    Del Mastro, Lucia
    FUTURE ONCOLOGY, 2013, 9 (07) : 955 - 957
12345